Neratinib fda first approval date?

When did the FDA first approve neratinib?

Neratinib (marketed as Nerlynx) received its first FDA approval on July 17, 2017. [1]

What was neratinib approved for in 2017?

That initial FDA approval was for extended adjuvant treatment of adult patients with early-stage HER2-overexpressed/amplified breast cancer, following treatment with adjuvant trastuzumab-based therapy. [1]

Where can I verify the approval date?

You can verify the FDA approval information using DrugPatentWatch’s drug page for neratinib. [1]

Sources:
[1] https://www.drugpatentwatch.com/patent/neratinib